医療従事者の為の最新医療ニュースや様々な情報・ツールを提供する医療総合サイト

New High-Tech Laser Method Allows DNA to be Inserted ‘Gently’ into Living Cells

2013年08月08日 AM04:55
このエントリーをはてなブックマークに追加


 

WASHINGTON

The applications of gene therapy and genetic engineering are broad: everything from pet fish that glow red to increased crop yields worldwide to cures for many of the diseases that plague humankind. But realizing them always starts with solving the same basic scientific question—how to “transfect” a cell by inserting foreign DNA into it. Many methods already exist for doing this, but they tend to be clumsy and destructive, not allowing researchers to precisely control how and when they insert the DNA or requiring them to burn through large numbers of cells before they can get it into one.

A team of scientists in South Korea have now developed the most precise method ever used to insert DNA into cells. The method combines two high-tech laboratory techniques and allows the researchers to precisely poke holes on the surface of a single cell with a high-powered “femtosecond” laser and then gently tug a piece of DNA through it using “optical tweezers,” which draw on the electromagnetic field of another laser. The team’s approach, which is a breakthrough in precision and control at the single-cell level, was published today in the Optical Society’s (OSA) open-access journal Biomedical Optics Express.

“What is magical is that all this happens for one cell,” said Yong-Gu Lee, an associate professor in the School of Mechatronics at the Gwangju Institute of Science and Technology in South Korea and one of the researchers who carried out the study. “Until today, gene transfection has been performed on a large quantity of agglomerate cells and the outcome has been observed as a statistical average and no observations have been made on individual cells.”

Common techniques to force DNA into cells can be clumsy or even violent, Lee said. For instance, researchers often use so-called “gene guns” to fire particles coated with strands of DNA known as plasmids at large populations of cells. Alternatively, scientists may puncture the membranes of individual cells with lasers, place the cells in a plasmid soup, and let the genes diffuse into the perforated cells on their own. While either method can transfect some fraction of a population, researchers cannot control whether any individual cell will incorporate the desired genes, and large numbers of cells may be damaged or destroyed in the process.

In the new study, the researchers sought to safely transfect an individual cell. To manipulate the foreign DNA, the scientists used optical tweezers, which essentially tweaks a laser beam whose electromagnetic field can grab hold of and transport a plasmid-coated particle. The researchers first moved the particle to the surface of the cell membrane. Guided by the trapped particle, they then created a tiny pore in the cell membrane using an ultra-short laser pulse from a femtosecond laser. While another laser beam detected the exact location of the cell membrane, they pushed the particle through the pore with the tweezers. Using this technique, the scientists were able to ease a microparticle right up to the pore in the membrane and drop it into the cell, like a golfer sinking an easy putt.

To determine whether their method had succeeded, the researchers inserted plasmids carrying a gene that codes for a green fluorescent protein. Once inside the cell, the gene became active and the cell’s machinery began producing the protein. The researchers could then detect the green glow using a fluorescence microscope. They found that approximately one in six of the cells they studied became transfected. This rate is lower than that recorded for some other methods, but those are less precise and involve many cells at a time.

Lee hopes the work will allow other researchers to investigate the effects of transfection on individual cells, not just large populations. With the new technique, “you can put one gene into one cell, another gene into another cell, and none into a third,” he said. “So you can study exactly how it works.”

Paper: “Single-cell optoporation and transfection using femtosecond laser and optical tweezers,” M. Waleed et al., Biomedical Optics Express, Vol. 4, Issue 9, pp. 1533-1547 (2013).

EDITOR’S NOTE: Images are available to members of the media upon request. Contact Angela Stark, astark@osa.org.

About Biomedical Optics Express

Biomedical Optics Express is OSA’s principal outlet for serving the biomedical optics community with rapid, open-access, peer-reviewed papers related to optics, photonics and imaging in the life sciences. The journal scope encompasses theoretical modeling and simulations, technology development, and biomedical studies and clinical applications. It is published by the Optical Society and edited by Joseph A. Izatt of Duke University. Biomedical Optics Express is an open-access journal and is available at no cost to readers online at www.OpticsInfoBase.org/BOE.

About OSA

Uniting more than 180,000 professionals from 175 countries, the Optical Society (OSA) brings together the global optics community through its programs and initiatives. Since 1916 OSA has worked to advance the common interests of the field, providing educational resources to the scientists, engineers and business leaders who work in the field by promoting the science of light and the advanced technologies made possible by optics and photonics. OSA publications, events, technical groups and programs foster optics knowledge and scientific collaboration among all those with an interest in optics and photonics. For more information, visit www.osa.org.

Photos/Multimedia Gallery Available: http://www.businesswire.com/multimedia/home/20130807006352/en/

CONTACT

The Optical Society
Angela Stark, 202-416-1443
astark@osa.org

同じカテゴリーの記事 

  • Poxel to Report Its 2023 Annual Results by the End of April 2024
  • Kolmar Korea Wins Case Against Italian Cosmetics Maker Intercos for Suncare Technology Theft
  • 大手CDMOのPCIファーマ・サービシズが初の包括ESG報告書を発表
  • Aurion Biotech Announces First Canadian Subject Dosed in Phase 1 / 2 Clinical Trial
  • 领先的合同开发和制造组织PCI Pharma Services发布首份综合ESG报告